Brookshire: Yes, the first GLP-1 receptor agonists were approved for diabetes, and thats partially because they increase insulin secretion, which is very important if you have type 2 diabetes and you are less sensitive to insulin or you dont produce enough insulin
651,652 Similarly, CR-boosted NAD + level protects the brain against aging and diseases through attenuating plasma membrane lipid peroxidation, protein carbonyls, nitrotyrosine and oxidative stress
On August 18, 2025, the U.S
Nonalcoholic fatty liver disease, or NAFLD, is now the most common cause of chronic liver disease in our country, far surpassing alcohol-related liver disease
References 1 RuscioAMSteinDJChiuWTKesslerRC
Both Semaglutide and Tirzepatide can be effective options for improving blood sugar control and promoting weight loss